Toragen, Inc.
PrivateLast Round
Convertible Debt
Oct 7, 2025
Total Funding Raised
$17.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Toragen, Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Convertible Debt round in October 2025.
Toragen, Inc. is a clinical-stage biotechnology company that develops novel small molecule inhibitors to treat cancers caused by the human papillomavirus (HPV).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Toragen, Inc. Comparables
Compare Toragen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kovina Therapeutics | 84% | |
| Flow Pharma, Inc. | 73% | |
| PapiVax Biotech, Inc. | 72% |
For institutional investors. Book with your work email.
Toragen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 7, 2025 | ||||
| Seed | Sep 30, 2022 |
For institutional investors. Book with your work email.
Toragen, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GenHenn Capital | Convertible Debt |
| The Raptor Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 31% MoM.
- Jul 26, 2026
Monthly visitors grew 430% MoM, from 263 to 1.4K.
For institutional investors. Book with your work email.
Toragen, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Toragen, Inc.'s valuation, stock price, and market status.
Is Toragen, Inc. a public or private company?
Toragen, Inc. is a private company.
What is the current stock price of Toragen, Inc.?
Toragen, Inc. is a private company, so its shares have no public market price. Caplight tracks Toragen, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Toragen, Inc. worth (valuation)?
Valuation information for Toragen, Inc. is not publicly available.
Can I buy Toragen, Inc. stock?
Toragen, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Toragen, Inc.'s last funding round?
Toragen, Inc.'s most recent funding round was Convertible Debt on October 7, 2025.
Who are the main investors in Toragen, Inc.?
Key investors in Toragen, Inc. include GenHenn Capital, The Raptor Group.
Will Toragen, Inc. IPO soon?
No public IPO plans have been announced for Toragen, Inc..
How can I track Toragen, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Toragen, Inc.'s shares on secondary markets.